Patients who are more than 10 years post-OLTX have CRF and ESRD at a high rate. The development of ESRD decreases survival, particularly in those patients treated with dialysis only. Patients who develop ESRD have a higher preoperative and 1-year serum creatinine and are more likely to have hepatorenal syndrome. However, an increase of serum creatinine at various times postoperatively is more predictive of the development of CRF or ESRD. New strategies for long-term immunosuppression may be needed to decrease this complication.
Although previous consensus recommendations have helped define patients who would benefit from simultaneous liver-kidney transplantation (SLK), there is a current need to reassess published guidelines for SLK because of continuing increase in proportion of liver transplant candidates with renal dysfunction and ongoing donor organ shortage. The purpose of this consensus meeting was to critically evaluate published and registry data regarding patient and renal outcomes following liver transplantation alone or SLK in liver transplant recipients with renal dysfunction. Modifications to the current guidelines for SLK and a research agenda were proposed.
The incidence of acute kidney injury (AKI) has been reported to vary between 17% and 95% post-orthotopic liver transplantation. This variability may be related to the absence of a uniform definition of AKI in this setting. The purpose of this study was to identify the degree of AKI that is associated with long-term adverse outcome. Furthermore, to determine the best definition (for use in future studies) of AKI not requiring dialysis in post-liver transplant patients, we retrospectively reviewed the effect of 3 definitions of AKI post-orthotopic liver transplantation on renal and patient outcome between 1997 and 2005. We compared patients with AKI to a control group without AKI by each definition. AKI was defined in 3 groups as an acute rise in serum creatinine, from the pretransplant baseline, of Ͼ0.5 mg/dL, Ͼ1.0 mg/dL, or Ͼ50% above baseline to a value above 2 mg/dL. In all groups, the glomerular filtration rate was significantly lower at both 1 and 2 years post-transplant. Patient survival was worse in all groups. Graft survival was worse in all groups. The incidence of AKI was highest in the group with a rise in creatinine of Ͼ0.5 mg/dL (78%) and lowest in patients with a rise in creatinine of Ͼ50% above 2.0 mg/dL (14%). Even mild AKI, defined as a rise in serum creatinine of Ͼ0.5 mg/dL, was associated with reduced patient and graft survival. However, in comparison with the other definitions, the definition of AKI with the greatest impact on patient's outcome post-liver transplant was a rise in serum creatinine of Ͼ50% above baseline to Ͼ2 mg/dL.
See Editorial on Page 455Acute kidney injury (AKI) is a frequent complication post-liver transplantation. The incidence has been reported to range between 17% and 95% in different studies. [1][2][3][4] The etiology of AKI post-liver transplantation is usually multifactorial. These factors include surgeryrelated events, blood loss, hypotension, sepsis, calcineurin inhibitor (CNI)-induced vasoconstriction, and volume depletion. 4 At our institution, we tend to target a lower central venous pressure to protect the liver transplant against passive congestion with subsequent worsening of preservation injury in the immediate posttransplant period. Furthermore, renal dysfunction may be present prior to transplantation because of hepatorenal syndrome or other factors such as infections or intravascular volume depletion. [5][6][7] Therefore, a rise in serum creatinine is common post-liver transplantation. A high burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been reported postliver transplantation, most frequently due to CNI-induced nephrotoxicity.8 However, other factors may contribute to the development of this complication. 8,9 A report from our institution has shown that the incidence of ESRD is 9.5% after 13 years of follow-up postliver transplantation.10 AKI has been proposed to be an important risk factor for the long-term development of CKD and ESRD.9 However, most of the studies have been limited to AKI requiring renal replacement the...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.